Selected research
Market Analysis & Forecast
Global External Anthelmintic for Dogs Market Analysis and Forecast 2026-2032
Market perspective
The global External Anthelmintic for Dogs market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
The US & Canada market for External Anthelmintic for Dogs is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
Europe market for External Anthelmintic for Dogs is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
Read the full market overview
Asia-Pacific market for External Anthelmintic for Dogs is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
The China market for External Anthelmintic for Dogs is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
The major global manufacturers of External Anthelmintic for Dogs include FRONTLINE, Zoetis, Bayer, Virbac, Vetoquinol, NexGard, Merck Animal Health, Elanco and Boehringer Ingelheim, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.
This report presents an overview of global market for External Anthelmintic for Dogs, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.
This report researches the key producers of External Anthelmintic for Dogs, also provides the sales of main regions and countries. Of the upcoming market potential for External Anthelmintic for Dogs, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the External Anthelmintic for Dogs sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global External Anthelmintic for Dogs market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for External Anthelmintic for Dogs sales, projected growth trends, production technology, application and end-user industry.
External Anthelmintic for Dogs Segment by Company
FRONTLINE
Zoetis
Bayer
Virbac
Vetoquinol
NexGard
Merck Animal Health
Elanco
Boehringer Ingelheim
External Anthelmintic for Dogs Segment by Type
Spray
Drops
External Anthelmintic for Dogs Segment by Application
Research Institutions
Veterinary Clinics
Animal Shelters
Pet Owners
Others
External Anthelmintic for Dogs Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global External Anthelmintic for Dogs market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of External Anthelmintic for Dogs and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of External Anthelmintic for Dogs.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Sales (consumption), revenue of External Anthelmintic for Dogs in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 4: Detailed analysis of External Anthelmintic for Dogs manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, External Anthelmintic for Dogs sales, revenue, price, gross margin, and recent development, etc.
Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.
Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.
Chapter 10: China type, by application, sales, and revenue for each segment.
Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.
Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.
Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.
Chapter 14: The main concluding insights of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Spray
- Drops
Applications
- Research Institutions
- Veterinary Clinics
- Animal Shelters
- Pet Owners
- Others
Companies covered
- FRONTLINE
- Zoetis
- Bayer
- Virbac
- Vetoquinol
- NexGard
- Merck Animal Health
- Elanco
- Boehringer Ingelheim
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 External Anthelmintic for Dogs Market by Type
- 1.2.1 Global External Anthelmintic for Dogs Market Size by Type, 2021 VS 2025 VS 2032
- 1.2.2 Spray
- 1.2.3 Drops
- 1.3 External Anthelmintic for Dogs Market by Application
- 1.3.1 Global External Anthelmintic for Dogs Market Size by Application, 2021 VS 2025 VS 2032
- 1.3.2 Research Institutions
- 1.3.3 Veterinary Clinics
- 1.3.4 Animal Shelters
- 1.3.5 Pet Owners
- 1.3.6 Others
- 1.4 Assumptions and Limitations
- 1.5 Study Goals and Objectives
2 External Anthelmintic for Dogs Market Dynamics
- 2.1 External Anthelmintic for Dogs Industry Trends
- 2.2 External Anthelmintic for Dogs Industry Drivers
- 2.3 External Anthelmintic for Dogs Industry Opportunities and Challenges
- 2.4 External Anthelmintic for Dogs Industry Restraints
3 Global Market Growth Prospects
- 3.1 Global External Anthelmintic for Dogs Revenue Estimates and Forecasts (2021-2032)
- 3.2 Global External Anthelmintic for Dogs Revenue by Region
- 3.2.1 Global External Anthelmintic for Dogs Revenue by Region: 2021 VS 2025 VS 2032
- 3.2.2 Global External Anthelmintic for Dogs Revenue by Region (2021-2026)
- 3.2.3 Global External Anthelmintic for Dogs Revenue by Region (2027-2032)
- 3.2.4 Global External Anthelmintic for Dogs Revenue Market Share by Region (2021-2032)
- 3.3 Global External Anthelmintic for Dogs Sales Estimates and Forecasts 2021-2032
- 3.4 Global External Anthelmintic for Dogs Sales by Region
- 3.4.1 Global External Anthelmintic for Dogs Sales by Region: 2021 VS 2025 VS 2032
- 3.4.2 Global External Anthelmintic for Dogs Sales by Region (2021-2026)
- 3.4.3 Global External Anthelmintic for Dogs Sales by Region (2027-2032)
- 3.4.4 Global External Anthelmintic for Dogs Sales Market Share by Region (2021-2032)
- 3.5 US & Canada & Mexico
- 3.6 Europe
- 3.7 China
- 3.8 Asia (Excluding China)
- 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
- 4.1 Global External Anthelmintic for Dogs Revenue by Manufacturers
- 4.1.1 Global External Anthelmintic for Dogs Revenue by Manufacturers (2021-2026)
- 4.1.2 Global External Anthelmintic for Dogs Revenue Market Share by Manufacturers (2021-2026)
- 4.1.3 Global External Anthelmintic for Dogs Manufacturers Revenue Share Top 10 and Top 5 in 2025
- 4.2 Global External Anthelmintic for Dogs Sales by Manufacturers
- 4.2.1 Global External Anthelmintic for Dogs Sales by Manufacturers (2021-2026)
- 4.2.2 Global External Anthelmintic for Dogs Sales Market Share by Manufacturers (2021-2026)
- 4.2.3 Global External Anthelmintic for Dogs Manufacturers Sales Share Top 10 and Top 5 in 2025
- 4.3 Global External Anthelmintic for Dogs Sales Price by Manufacturers (2021-2026)
- 4.4 Global External Anthelmintic for Dogs Key Manufacturers Ranking, 2024 VS 2025 VS 2026
- 4.5 Global External Anthelmintic for Dogs Key Manufacturers Manufacturing Sites & Headquarters
- 4.6 Global External Anthelmintic for Dogs Manufacturers, Product Type & Application
- 4.7 Global External Anthelmintic for Dogs Manufacturers' Establishment Date
- 4.8 Market Competitive Analysis
- 4.8.1 Global External Anthelmintic for Dogs Market CR5 and HHI
- 4.8.2 2025 External Anthelmintic for Dogs Tier 1, Tier 2, and Tier 3
5 External Anthelmintic for Dogs Market by Type
- 5.1 Global External Anthelmintic for Dogs Revenue by Type
- 5.1.1 Global External Anthelmintic for Dogs Revenue by Type (2021 VS 2025 VS 2032)
- 5.1.2 Global External Anthelmintic for Dogs Revenue by Type (2021-2032) & (US$ Million)
- 5.1.3 Global External Anthelmintic for Dogs Revenue Market Share by Type (2021-2032)
- 5.2 Global External Anthelmintic for Dogs Sales by Type
- 5.2.1 Global External Anthelmintic for Dogs Sales by Type (2021 VS 2025 VS 2032)
- 5.2.2 Global External Anthelmintic for Dogs Sales by Type (2021-2032) & (kg)
- 5.2.3 Global External Anthelmintic for Dogs Sales Market Share by Type (2021-2032)
- 5.3 Global External Anthelmintic for Dogs Price by Type
6 External Anthelmintic for Dogs Market by Application
- 6.1 Global External Anthelmintic for Dogs Revenue by Application
- 6.1.1 Global External Anthelmintic for Dogs Revenue by Application (2021 VS 2025 VS 2032)
- 6.1.2 Global External Anthelmintic for Dogs Revenue by Application (2021-2032) & (US$ Million)
- 6.1.3 Global External Anthelmintic for Dogs Revenue Market Share by Application (2021-2032)
- 6.2 Global External Anthelmintic for Dogs Sales by Application
- 6.2.1 Global External Anthelmintic for Dogs Sales by Application (2021 VS 2025 VS 2032)
- 6.2.2 Global External Anthelmintic for Dogs Sales by Application (2021-2032) & (kg)
- 6.2.3 Global External Anthelmintic for Dogs Sales Market Share by Application (2021-2032)
- 6.3 Global External Anthelmintic for Dogs Price by Application
7 Company Profiles
- 7.1 FRONTLINE
- 7.1.1 FRONTLINE Company Information
- 7.1.2 FRONTLINE Business Overview
- 7.1.3 FRONTLINE External Anthelmintic for Dogs Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.1.4 FRONTLINE External Anthelmintic for Dogs Product Portfolio
- 7.1.5 FRONTLINE Recent Developments
- 7.2 Zoetis
- 7.2.1 Zoetis Company Information
- 7.2.2 Zoetis Business Overview
- 7.2.3 Zoetis External Anthelmintic for Dogs Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.2.4 Zoetis External Anthelmintic for Dogs Product Portfolio
- 7.2.5 Zoetis Recent Developments
- 7.3 Bayer
- 7.3.1 Bayer Company Information
- 7.3.2 Bayer Business Overview
- 7.3.3 Bayer External Anthelmintic for Dogs Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.3.4 Bayer External Anthelmintic for Dogs Product Portfolio
- 7.3.5 Bayer Recent Developments
- 7.4 Virbac
- 7.4.1 Virbac Company Information
- 7.4.2 Virbac Business Overview
- 7.4.3 Virbac External Anthelmintic for Dogs Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.4.4 Virbac External Anthelmintic for Dogs Product Portfolio
- 7.4.5 Virbac Recent Developments
- 7.5 Vetoquinol
- 7.5.1 Vetoquinol Company Information
- 7.5.2 Vetoquinol Business Overview
- 7.5.3 Vetoquinol External Anthelmintic for Dogs Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.5.4 Vetoquinol External Anthelmintic for Dogs Product Portfolio
- 7.5.5 Vetoquinol Recent Developments
- 7.6 NexGard
- 7.6.1 NexGard Company Information
- 7.6.2 NexGard Business Overview
- 7.6.3 NexGard External Anthelmintic for Dogs Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.6.4 NexGard External Anthelmintic for Dogs Product Portfolio
- 7.6.5 NexGard Recent Developments
- 7.7 Merck Animal Health
- 7.7.1 Merck Animal Health Company Information
- 7.7.2 Merck Animal Health Business Overview
- 7.7.3 Merck Animal Health External Anthelmintic for Dogs Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.7.4 Merck Animal Health External Anthelmintic for Dogs Product Portfolio
- 7.7.5 Merck Animal Health Recent Developments
- 7.8 Elanco
- 7.8.1 Elanco Company Information
- 7.8.2 Elanco Business Overview
- 7.8.3 Elanco External Anthelmintic for Dogs Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.8.4 Elanco External Anthelmintic for Dogs Product Portfolio
- 7.8.5 Elanco Recent Developments
- 7.9 Boehringer Ingelheim
- 7.9.1 Boehringer Ingelheim Company Information
- 7.9.2 Boehringer Ingelheim Business Overview
- 7.9.3 Boehringer Ingelheim External Anthelmintic for Dogs Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.9.4 Boehringer Ingelheim External Anthelmintic for Dogs Product Portfolio
- 7.9.5 Boehringer Ingelheim Recent Developments
8 North America
- 8.1 North America External Anthelmintic for Dogs Market Size by Type
- 8.1.1 North America External Anthelmintic for Dogs Revenue by Type (2021-2032)
- 8.1.2 North America External Anthelmintic for Dogs Sales by Type (2021-2032)
- 8.1.3 North America External Anthelmintic for Dogs Price by Type (2021-2032)
- 8.2 North America External Anthelmintic for Dogs Market Size by Application
- 8.2.1 North America External Anthelmintic for Dogs Revenue by Application (2021-2032)
- 8.2.2 North America External Anthelmintic for Dogs Sales by Application (2021-2032)
- 8.2.3 North America External Anthelmintic for Dogs Price by Application (2021-2032)
- 8.3 North America External Anthelmintic for Dogs Market Size by Country
- 8.3.1 North America External Anthelmintic for Dogs Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
- 8.3.2 North America External Anthelmintic for Dogs Sales by Country (2021 VS 2025 VS 2032)
- 8.3.3 North America External Anthelmintic for Dogs Price by Country (2021-2032)
- 8.3.4 United States
- 8.3.5 Canada
- 8.3.6 Mexico
9 Europe
- 9.1 Europe External Anthelmintic for Dogs Market Size by Type
- 9.1.1 Europe External Anthelmintic for Dogs Revenue by Type (2021-2032)
- 9.1.2 Europe External Anthelmintic for Dogs Sales by Type (2021-2032)
- 9.1.3 Europe External Anthelmintic for Dogs Price by Type (2021-2032)
- 9.2 Europe External Anthelmintic for Dogs Market Size by Application
- 9.2.1 Europe External Anthelmintic for Dogs Revenue by Application (2021-2032)
- 9.2.2 Europe External Anthelmintic for Dogs Sales by Application (2021-2032)
- 9.2.3 Europe External Anthelmintic for Dogs Price by Application (2021-2032)
- 9.3 Europe External Anthelmintic for Dogs Market Size by Country
- 9.3.1 Europe External Anthelmintic for Dogs Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
- 9.3.2 Europe External Anthelmintic for Dogs Sales by Country (2021 VS 2025 VS 2032)
- 9.3.3 Europe External Anthelmintic for Dogs Price by Country (2021-2032)
- 9.3.4 Germany
- 9.3.5 France
- 9.3.6 U.K.
- 9.3.7 Italy
- 9.3.8 Russia
- 9.3.9 Spain
- 9.3.10 Netherlands
10 China
- 10.1 China External Anthelmintic for Dogs Market Size by Type
- 10.1.1 China External Anthelmintic for Dogs Revenue by Type (2021-2032)
- 10.1.2 China External Anthelmintic for Dogs Sales by Type (2021-2032)
- 10.1.3 China External Anthelmintic for Dogs Price by Type (2021-2032)
- 10.2 China External Anthelmintic for Dogs Market Size by Application
- 10.2.1 China External Anthelmintic for Dogs Revenue by Application (2021-2032)
- 10.2.2 China External Anthelmintic for Dogs Sales by Application (2021-2032)
- 10.2.3 China External Anthelmintic for Dogs Price by Application (2021-2032)
11 Asia (Excluding China)
- 11.1 Asia External Anthelmintic for Dogs Market Size by Type
- 11.1.1 Asia External Anthelmintic for Dogs Revenue by Type (2021-2032)
- 11.1.2 Asia External Anthelmintic for Dogs Sales by Type (2021-2032)
- 11.1.3 Asia External Anthelmintic for Dogs Price by Type (2021-2032)
- 11.2 Asia External Anthelmintic for Dogs Market Size by Application
- 11.2.1 Asia External Anthelmintic for Dogs Revenue by Application (2021-2032)
- 11.2.2 Asia External Anthelmintic for Dogs Sales by Application (2021-2032)
- 11.2.3 Asia External Anthelmintic for Dogs Price by Application (2021-2032)
- 11.3 Asia External Anthelmintic for Dogs Market Size by Country
- 11.3.1 Asia External Anthelmintic for Dogs Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
- 11.3.2 Asia External Anthelmintic for Dogs Sales by Country (2021 VS 2025 VS 2032)
- 11.3.3 Asia External Anthelmintic for Dogs Price by Country (2021-2032)
- 11.3.4 Japan
- 11.3.5 South Korea
- 11.3.6 India
- 11.3.7 Australia
- 11.3.8 Taiwan
- 11.3.9 Southeast Asia
12 South America, Middle East and Africa
- 12.1 SAMEA External Anthelmintic for Dogs Market Size by Type
- 12.1.1 SAMEA External Anthelmintic for Dogs Revenue by Type (2021-2032)
- 12.1.2 SAMEA External Anthelmintic for Dogs Sales by Type (2021-2032)
- 12.1.3 SAMEA External Anthelmintic for Dogs Price by Type (2021-2032)
- 12.2 SAMEA External Anthelmintic for Dogs Market Size by Application
- 12.2.1 SAMEA External Anthelmintic for Dogs Revenue by Application (2021-2032)
- 12.2.2 SAMEA External Anthelmintic for Dogs Sales by Application (2021-2032)
- 12.2.3 SAMEA External Anthelmintic for Dogs Price by Application (2021-2032)
- 12.3 SAMEA External Anthelmintic for Dogs Market Size by Country
- 12.3.1 SAMEA External Anthelmintic for Dogs Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
- 12.3.2 SAMEA External Anthelmintic for Dogs Sales by Country (2021 VS 2025 VS 2032)
- 12.3.3 SAMEA External Anthelmintic for Dogs Price by Country (2021-2032)
- 12.3.4 Brazil
- 12.3.5 Argentina
- 12.3.6 Chile
- 12.3.7 Colombia
- 12.3.8 Peru
- 12.3.9 Saudi Arabia
- 12.3.10 Israel
- 12.3.11 UAE
- 12.3.12 Turkey
- 12.3.13 Iran
- 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
- 13.1 External Anthelmintic for Dogs Value Chain Analysis
- 13.1.1 External Anthelmintic for Dogs Key Raw Materials
- 13.1.2 Raw Materials Key Suppliers
- 13.1.3 Manufacturing Cost Structure
- 13.1.4 External Anthelmintic for Dogs Production Mode & Process
- 13.2 External Anthelmintic for Dogs Sales Channels Analysis
- 13.2.1 Direct Comparison with Distribution Share
- 13.2.2 External Anthelmintic for Dogs Distributors
- 13.2.3 External Anthelmintic for Dogs Customers
14 Concluding Insights
15 Appendix
- 15.1 Reasons for Doing This Study
- 15.2 Research Methodology
- 15.3 Research Process
- 15.4 Authors List of This Report
- 15.5 Data Source
- 15.5.1 Secondary Sources
- 15.5.2 Primary Sources
- 15.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst